Drug Efficacy and Pharmacology CRO
Hera provides in vitro and in vivo contract research services for oncology, immuno oncology, metabolism, cell therapy, and gene therapy researchers. Starting with the Cas-CLOVER and piggyBac gene editing technologies, Hera is building novel preclinical models for improved predictability and translation- including humanized liver, humanized immune system, bioproduction platforms, transgenic animal models, etc.